CD22 CAR T Cell-Related IEC-HS Is Associated with an IFN-. Cytokine Signature

被引：2

作者：

Srinagesh, Hrishikesh ^{[1
]}

Baird, John H. ^{[2
]}

Agarwal, Neha ^{[1
]}

Su, Yi-Jiun ^{[1
]}

Kramer, Anne Marijn ^{[3
]}

Reschke, Agnes ^{[1
]}

Jeyakumar, Nikeshan ^{[1
]}

Bharadwaj, Sushma ^{[1
]}

Schultz, Liora Michal ^{[4
]}

Ramakrishna, Sneha ^{[5
]}

Davis, Kara L. ^{[6
]}

Sahaf, Bita ^{[7
]}

Feldman, Steven ^{[3
]}

Mackall, Crystal L. ^{[8
]}

Miklos, David B. ^{[9
]}

Muffly, Lori S. ^{[1
]}

Frank, Matthew J. ^{[9
]}

机构：

[1] Stanford Univ, Div Blood & Marrow Transplantat Cellular Therapy, Sch Med, Palo Alto, CA USA

[2] City Hope Natl Med Ctr, Dept Hematol & HCT, Duarte, CA USA

[3] Stanford Univ, Ctr Canc Cell Therapy, Stanford, CA USA

[4] Stanford Univ, Div Hematol & Oncol, Dept Pediat, Sch Med, Palo Alto, CA USA

[5] Stanford Univ, Div Hematol & Oncol, Dept Pediat, Sch Med, Palo Alto, CA USA

[6] Stanford Univ, Dept Pediat Hematol Oncol & Stem Cell Transplant, Stanford, CA USA

[7] Stanford Univ, Canc Correlat Sci Unit, Palo Alto, CA USA

[8] Stanford Univ, Stanford Canc Inst, Ctr Canc Cell Therapy, Stanford, CA USA

[9] Stanford Univ, Div Blood & Marrow Transplantat Cellular Therapy, Palo Alto, CA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-178283

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[31] Development and validation of a novel CD4+ T cell-related gene signature to detect severe COVID-19
Zhang, Da-Wei
Li, Fang
Wei, Yuan-Yuan
Hu, Lei
Chen, Su-Hong
Yang, Ming-Ming
Zhang, Wen-Ting
Fei, Guang-He
CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (06):
[32] CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Spiegel, Jay Y.
Patel, Shabnum
Muffly, Lori
Hossain, Nasheed M.
Oak, Jean
Baird, John H.
Frank, Matthew J.
Shiraz, Parveen
Sahaf, Bita
Craig, Juliana
Iglesias, Maria
Younes, Sheren
Natkunam, Yasodha
Ozawa, Michael G.
Yang, Eric
Tamaresis, John
Chinnasamy, Harshini
Ehlinger, Zach
Reynolds, Warren
Lynn, Rachel
Rotiroti, Maria Caterina
Gkitsas, Nikolaos
Arai, Sally
Johnston, Laura
Lowsky, Robert
Majzner, Robbie G.
Meyer, Everett
Negrin, Robert S.
Rezvani, Andrew R.
Sidana, Surbhi
Shizuru, Judith
Weng, Wen-Kai
Mullins, Chelsea
Jacob, Allison
Kirsch, Ilan
Bazzano, Magali
Zhou, Jing
Mackay, Sean
Bornheimer, Scott J.
Schultz, Liora
Ramakrishna, Sneha
Davis, Kara L.
Kong, Katherine A.
Shah, Nirali N.
Qin, Haiying
Fry, Terry
Feldman, Steven
Mackall, Crystal L.
Miklos, David B.
NATURE MEDICINE, 2021, 27 (08) : 1419 - +
[33] Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma
Huang, Lefu
Li, Jingjing
Yang, Junfang
Zhang, Xian
Zhang, Min
He, Jiujiang
Zhang, Gailing
Li, Wenqian
Wang, Hui
Li, Jianqiang
Lu, Peihua
CELLS, 2022, 11 (24)
[34] Development of fully human anti-CD19 &CD22 bispecific tandem CAR-T for the treatment of resistant or relapsed B cell malignancies
Nguyen, Jenna
Zhang, Gening
Zhang, Keming
Jiang, Ning
Feng, Ryan
Wong, Jeffrey
Luu, Annie
Chen, Yan
Zhao, Kehao
CANCER RESEARCH, 2022, 82 (12)
[35] Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma
Roddie, Claire
Lekakis, Lazaros J.
Marzolini, Maria A. V.
Ramakrishnan, Aravind
Zhang, Yiyun
Hu, Yanqing
Peddareddigari, Vijay G. R.
Khokhar, Nushmia
Chen, Robert
Basilico, Silvia
Raymond, Meera
Vargas, Frederick Arce
Duffy, Kevin
Brugger, Wolfram
O'Reilly, Maeve A.
Wood, Leigh
Linch, David C.
Peggs, Karl S.
Bachier, Carlos
Budde, Elizabeth Lihua
Batlevi, Connie Lee
Bartlett, Nancy
Irvine, David
Tholouli, Eleni
Osborne, Wendy
Ardeshna, Kirit M.
Pule, Martin A.
BLOOD, 2023, 141 (20) : 2470 - 2482
[36] CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Jay Y. Spiegel
Shabnum Patel
Lori Muffly
Nasheed M. Hossain
Jean Oak
John H. Baird
Matthew J. Frank
Parveen Shiraz
Bita Sahaf
Juliana Craig
Maria Iglesias
Sheren Younes
Yasodha Natkunam
Michael G. Ozawa
Eric Yang
John Tamaresis
Harshini Chinnasamy
Zach Ehlinger
Warren Reynolds
Rachel Lynn
Maria Caterina Rotiroti
Nikolaos Gkitsas
Sally Arai
Laura Johnston
Robert Lowsky
Robbie G. Majzner
Everett Meyer
Robert S. Negrin
Andrew R. Rezvani
Surbhi Sidana
Judith Shizuru
Wen-Kai Weng
Chelsea Mullins
Allison Jacob
Ilan Kirsch
Magali Bazzano
Jing Zhou
Sean Mackay
Scott J. Bornheimer
Liora Schultz
Sneha Ramakrishna
Kara L. Davis
Katherine A. Kong
Nirali N. Shah
Haiying Qin
Terry Fry
Steven Feldman
Crystal L. Mackall
David B. Miklos
Nature Medicine, 2021, 27 : 1419 - 1431
[37] Decoding the immune microenvironment: unveiling CD8+T cell-related biomarkers and developing a prognostic signature for personalized glioma treatment
Lin, Xiaofang
Liu, Jianqiang
Zhang, Ni
Zhou, Dexiang
Liu, Yakang
CANCER CELL INTERNATIONAL, 2024, 24 (01)
[38] CD19/CD22 CAR T-Cell Therapy Following Autologous Transplantation Is an Optimizing Strategy in Relapsed/Refractory Central Nervous System Lymphoma
Yu, Qiuxia
Gang, Daizi
Wang, Jue
Huang, Liang
Li, Chunrui
Zhang, Yicheng
Zhou, Xiaoxi
Cao, Yang
BLOOD, 2023, 142
[39] Structural Optimization of Dual-Target CD22/CD19 CAR-T and Its Anti-Tumor Effects on B Cell Malignancies
Zhang, Yu
Wang, Ying
Gu, Runxia
Shi, Lin
Wang, Yongzeng
Feng, Yi
Lv, Lulu
Rao, Qing
Wang, Min
Wang, Jianxiang
BLOOD, 2022, 140
[40] CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study
Wei, Guoqing
Zhang, Yanlei
Zhao, Houli
Wang, Yiyun
Liu, Yandan
Liang, Bin
Wang, Xiujian
Xu, Huijun
Cui, Jiazhen
Wu, Wenjun
Zhao, Kui
Nagler, Arnon
Chang, Alex H.
Hu, Yongxian
Huang, He
CANCER IMMUNOLOGY RESEARCH, 2021, 9 (09) : 1061 - 1070

← 1 2 3 4 5 →